Supplementary Figure S4 from Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy

Authors :: Pierre Fons
Mark Whittaker
Ian Hunneyball
Antoine Alam
Isabelle Blanc
Françoise Bono
Frédérique Dol-Gleizes
Jean-Pierre Delord
Céleste Lebbé
Maxime Battistella
Philippe Rochaix
Janik Selves
Anne Gomez-Brouchet
Valérie Martin
Jérôme Meneyrol
Dennis Özcelik
Eric Erdociain
David Sibrac
Pierre-Benoit Ancey
Anne Briaux
Gaelle Badet
Pauline Barron
Florence Gaujarengues
Geneviève Gueguen-Dorbes
Virgile Visentin
Mélanie Pichery
Céline Poussereau-Pomié
Florie A. Bertrand
Michael Esquerré
Michael R. Paillasse
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure S4 shows the evaluation of EVT801’s pharmacokinetics and pharmacodynamics

Full Text Access

Tools